FDA
approval
· 2025-02-10
FDA Approved: LEVETIRACETAM — Supplemental Application (Mylan Pharmaceuticals Inc.)
Summary
The FDA approved a supplemental application for Levetiracetam submitted by Mylan Pharmaceuticals Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)